Clinical Trial

The Hepatitis C Transplant Collaborative

Recruiting
View on ClinicalTrials.gov →
Summary
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-07-29; most recent amendment 2026-01-20.
Trial Details
NCT Number NCT04493385
Lead Sponsor Baylor Research Institute
Conditions Transplant; Failure, Heart, Hepatitis C
Enrollment 500 participants
Start Date 2019-09-16
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-22